Literature DB >> 18270702

Reversal of P-glycoprotein-mediated multidrug resistance of cancer cells by five schizandrins isolated from the Chinese herb Fructus Schizandrae.

Min Huang1, Jing Jin, Hua Sun, Geng Tao Liu.   

Abstract

PURPOSE: Fructus Schizandrae (FS) is commonly used as a tonic in traditional Chinese medicine. Recently, FS was found to significantly improve liver dysfunction in chronic hepatitis patients. The present study was to assess the reversal effect of five schizandrins and crude extract from FS (named LCC) on multidrug resistance (MDR) of cancer cells, both in vitro and in vivo. Chemically, the five schizandins are derivatives of dibenzo-(a, c)-cyclooctene lignan with distinct structures differing from any known MDR reversal agents.
METHODS: A panel of sensitive and resistant cancer cell lines were treated with various concentrations of LCC and schizandrins. Drug sensitivity, accumulation of Doxorubicin (Dox), expression of P-glycoprotein and protein kinase C (PKC), and apoptosis were determined in vitro. The in vivo effect was tested in nude mice grafted with sensitive and resistant human epidermal cancer cell line to vincristine (VCR) (KB, KBv200).
RESULTS: The tested five compounds at 25 muM showed various levels of MDR reversal activity, of which, schizandrin A (Sin A) was the most potent one. Sin A reversed VCR resistance in KBv200 cells, MCF-7/Dox cells and Bel7402 cells by 309-, 38-, and 84-folds, respectively. Also, Sin A reversed the resistance of Dox in the above cancer cell lines. LCC at 25 mug/ml reversed VCR resistance by 619-folds in KBv200, 181-folds in MCF-7/Dox cell line, and 1,563-folds in innate resistance of human hepatic cellular carcinoma Bel7402 cells to VCR. Furthermore, LCC and its active component Sin A potently reversed the cross-resistance to paclitaxel in those cell lines. Both Sin A and LCC markedly increased intracellular Dox accumulation and enhanced apoptosis, down-regulated Pgp protein and mRNA and total PKC expression in MDR cells. Coadministration of LCC (p.o.) significantly potentiated the inhibitory effect of VCR (i.p.) on tumor growth in nude mice bearing KBv200 xenograft.
CONCLUSIONS: The LCC and its active component Sin A have remarkable reversal effect on MDR in cancer cells by inhibition of both the function and expression of Pgp and total PKC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270702     DOI: 10.1007/s00280-008-0691-0

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  15 in total

1.  Schisandra chinensis reverses visceral hypersensitivity in a neonatal-maternal separated rat model.

Authors:  Jia-Ming Yang; Yan-Fang Xian; Paul S P Ip; Justin C Y Wu; Lixing Lao; Harry H S Fong; Joseph J Y Sung; Brian Berman; John H K Yeung; Chun-Tao Che
Journal:  Phytomedicine       Date:  2012-01-09       Impact factor: 5.340

2.  Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.

Authors:  Stella Chai; Kenneth Kw To; Ge Lin
Journal:  Chin Med       Date:  2010-07-25       Impact factor: 5.455

3.  In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1.

Authors:  Hui Zhang; Atish Patel; Shao-Lin Ma; Xiao Jie Li; Yun-Kai Zhang; Pei-Qi Yang; Rishil J Kathawala; Yi-Jun Wang; Nagaraju Anreddy; Li-Wu Fu; Zhe-Sheng Chen
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

4.  A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophageal carcinoma treatment through overcoming multidrug resistance.

Authors:  Xiangyu Su; Chanchan Gao; Fangfang Shi; Xiaoyao Feng; Lin Liu; Ding Qu; Cailian Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

5.  Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo.

Authors:  Yang Xu; Zhen Liu; Jie Sun; Qiangrong Pan; Feifei Sun; Zhiyu Yan; Xun Hu
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

6.  Herb-drug pharmacokinetic interaction of a traditional chinese medicine jia-wei-xiao-yao-san with 5-Fluorouracil in the blood and brain of rat using microdialysis.

Authors:  Meng-Hsuan Chiang; Li-Wen Chang; Ju-Wen Wang; Lie-Chwen Lin; Tung-Hu Tsai
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-10       Impact factor: 2.629

7.  Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review).

Authors:  Chong DI; Yaodong Zhao
Journal:  Exp Ther Med       Date:  2014-12-16       Impact factor: 2.447

8.  Schisandrin B attenuates cancer invasion and metastasis via inhibiting epithelial-mesenchymal transition.

Authors:  Zhen Liu; Biao Zhang; Kun Liu; Zonghui Ding; Xun Hu
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.752

9.  Clinical Experiences of Korean Medicine Treatment against Urinary Bladder Cancer in General Practice.

Authors:  Taeyeol Park; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-12       Impact factor: 2.629

10.  Quinone derivatives isolated from the endolichenic fungus Phialocephala fortinii are Mdr1 modulators that combat azole resistance in Candida albicans.

Authors:  Fei Xie; Wenqiang Chang; Ming Zhang; Ying Li; Wei Li; Hongzhuo Shi; Sha Zheng; Hongxiang Lou
Journal:  Sci Rep       Date:  2016-09-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.